J&J vaccine to remain in limbo while officials seek evidence
Johnson & Johnson’s COVID-19 vaccine will remain in limbo for a while longer after government health advisers declared Wednesday that they need more evidence to decide if a handful of unusual blood clots were linked to the shot—and if so, how big the risk really is.
